Biomarker May Help Predict Oropharyngeal Cancer Recurrence

HPV-related oropharyngeal cancers are among the most common types of this disease. Affecting the tongue, tonsils, soft palate and pharynx, about 80 percent of these cancers are attributed to human papillomavirus (HPV) infections. Although often quite treatable, more than 25 percent of HPV-related cancers recur. In most cases, the recurrence happens within the first two […]

Radiation, Androgen Deprivation Not Best Option For All Prostate Cancers

While a number of studies have shown that androgen deprivation therapy combined with radiation can provide a powerful one-two punch to treat prostate cancer, this combination option may not be right in all cases. A recent study shows that men with unfavorable-risk prostate cancer who have other medical concerns, such as a prior heart attack, […]

Combination Therapy May Help Lung Cancer Patients

Lung cancer remains one of the deadliest forms of this disease diagnosed in the United States. An estimated 224,000 Americans, men and women alike, will be diagnosed with the disease this year alone. Some 158,000 will die from lung cancer. While the overall survival rate has improved courtesy of earlier interventions and more advanced treatments, […]

Patients Frustrated By Lack Of Information On Neuroendocrine Tumors

While most people are familiar with breast, prostate, lung and colon cancer, few have heard about the dangers neuroendocrine tumors pose. After all, with only about five out every 100,000 Americans affected by this disease, the frequency of its diagnosis hasn’t exactly put it in the spotlight. The low frequency rate, however, is seen as […]